Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Operating activities:
Net loss	$ (3,776,857)	$ (1,225,669)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	561,541	239,577
Loss on marketable securities	493,796
Interest expense	200,000	236,996
Share-based compensation	86,512
Provision for losses on receivables, net	63,309
Provision for obsolete inventory	41,000
Gain on sales of assets	(265,927)
Deferred income tax	45,000
Changes in certain assets and liabilities:
Accounts receivable	(268,656)	41,579
Inventory	1,266,405	205,040
Other current assets	182,037	(63,093)
Accounts payable and accrued expenses	(828,298)	88,934
Accounts payable-related party	(131,617)	(158,729)
Deferred revenue	1,204,568	(169,826)
Other long-term liabilities	85,952
Net cash (used in) provided by operating activities	(1,041,235)	(805,191)
Investing activities:
Capital expenditures	(335,352)
Proceeds from the sale of property, plant and equipment	1,333,857
Sale of marketable securities	3,417,704	0
Cash acquired in acquisition	2,000	84,062
Net cash (used in) provided by investing activities	4,418,209	84,062
Financing activities:
Line of credit, net change	(1,430,168)	421,299
Repayments on long-term debt	(613,762)	(31,374)
Net cash (used in) provided by financing activities	(2,043,930)	389,925
Effect of exchange rate changes on cash	(9,602)
Increase (decrease) in cash	1,323,442	(331,204)
Cash and cash equivalents at beginning of year	3,876,708	19,032,392
Cash and cash equivalents at end of period	5,200,150	18,701,188
Cash paid during the year for:
Interest	65,191
Income taxes	122,000
Non-cash transactions:
Convertible note issued related to acquisition		6,500,000
Promissory note issued related to acquisition		4,000,000
Stock issued for purchase of subsidiaries	$ 484,067